TITOMIC
The inaugural CEO of Saudi Arabian Military Industries (SAMI), Dr Andreas Schwer, has been appointed Chairman of the Melbourne-based industrial-scale additive manufacturing company Titomic (ASX:TTT) www.titomic.com .
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200701005306/en/
Beginning immediately, Dr Schwer, who boasts a 25-year career in the global defence, manufacturing, and aerospace industries will bring a wealth of experience to Titomic. The news comes just days after Titomic announced the appointments of Mr Dag W.R. Stromme, a former Managing Director of Morgan Stanley; and Mr Humphrey Nolan, an experienced leader in the global industrial and distribution industries.
As the first CEO at SAMI, which was established in 2017, Dr Schwer led this greenfield operation to become a multi-billion-dollar company in 2020 before recently stepping down.
Prior to his role at SAMI, Dr Schwer was Chairman and President of Rheinmetall International - Rheinmetall AG. Dr Schwer also held roles including CEO of Combat Systems & Executive Board Member of Rheinmetall Defence overseeing the units of Combat Platforms, Weapons & Munitions, Protection Systems, and Propulsion Systems. Dr Schwer also holds 12 years’ experience at Airbus in executive roles across the Defence & Space and Helicopter divisions.
Titomic’s Managing Director and Founder, Mr. Jeff Lang, said: “Andreas’ extensive professional experience in the global defence and aerospace sectors facilitates strong opportunities for Titomic to become a dominant player in the USD$4 trillion metals manufacturing industry for a green-tech future.”
Further, Dr Schwer stated; “I am honoured to accept the role of Chairman at Titomic and look forward to leading the Company to capitalise on its considerable opportunities and further add shareholder value. I believe Titomic’s industrial scale metal additive manufacturing and sustainable, green technology has tremendous commercial potential to take metal manufacturing industries into the future.”
Dr Schwer has a Dipl.-Ing in Aerospace Engineering and a PhD in System Modelling and Numerical Optimisation, both from the University of Stuttgart, and a Master of Science in System-Engineering from TU Delfi (The Netherlands).
Dr Schwer says he’s delighted to be joining the Board of a company that’s starting to make its presence felt globally, as demonstrated by the sale of two Titomic Kinetic Fusion® systems to a global defence manufacturer, as well as reaching agreements with companies of the calibre of Boeing, Airbus, and Thales.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200701005306/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LambdaTest and SVAM International Inc. Announce Partnership to Transform Quality Engineering for Businesses26.11.2025 18:00:00 CET | Press release
The alliance empowers enterprises with accelerated SDLC cycles, reduced testing effort, and modern AI-driven digital transformation capabilities LambdaTest, a Gen-AI native quality engineering platform, announced a partnership with SVAM International, Inc., a global leader in digital transformation services. This strategic alliance marks a significant step forward in their mission to transform quality engineering for businesses worldwide. The partnership allows LambdaTest to extend its AI-native quality engineering capabilities into SVAM’s extensive digital transformation ecosystem. By integrating with SVAM’s experience in large-scale application development, testing, and delivery across major New York State and City agencies, as well as their platform expertise across Salesforce, ServiceNow, and Dynamics365, LambdaTest will empower more enterprises to modernize their software delivery pipelines. With LambdaTest’s intelligent test orchestration and execution engine at the core, teams c
GLORY Acquires Remaining Equity Shares in Acrelec Group26.11.2025 16:11:00 CET | Press release
Acrelec becomes a wholly owned subsidiary of Glory Glory Global Solutions (International) Ltd, a wholly-owned subsidiary of GLORY Ltd. [TYO:6457], has announced the acquisition of the remaining equity shares in Acrelec Group SAS. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251126039437/en/ Acrelec is a global technology company focused on reinventing the customer experience for restaurant and retail brands. Leveraging decades of software, hardware and service expertise, the company develops and integrates new platforms that increase customer engagement, optimize efficiency and improve operations. With over 120,000 installations across more than 70 countries, Acrelec counts many of the world’s best-known restaurant mega-brands among its customers. We announce that Jalel Souissi has left the Acrelec Group following the completion of the recent share acquisition. Jalel Souissi has played a pivotal role in the development and
Andersen Global styrker sin platform i Tyrkiet med tilføjelsen af medlemsvirksomhed26.11.2025 14:49:00 CET | Pressemeddelelse
Andersen Global udvider sin tilstedeværelse i Tyrkiet, efter at Celen Corporate Property Valuation & Counseling Inc. bliver til Andersen i Tyrkiet, hvilket udvider de kompetencer, der tilbydes under Andersen-brandet i landet. Det Istanbul-baserede firma blev stiftet i 1995 og ledes af Managing Partner Guniz Celen med en bred vifte af ydelser til både nationale og internationale kunder. Med ekspertise inden for finansiering af fast ejendom, værdiansættelse af materielle og immaterielle aktiver samt formueforvaltning leverer den tyrkiske afdeling af Andersen løsninger, der understøtter komplekse finansielle beslutninger for kunder i mere end 18 lande. “Vores mission har altid været at levere løsninger på de mest komplekse udfordringer inden for ejendoms- og investeringssektoren,” sagde Guniz. “At blive en del af Andersen-brandet styrker vores kompetencer som en betroet rådgiver og giver os adgang til globale ressourcer, hvilket gør os i stand til at skabe endnu større langsigtet værdi fo
Cegid Acquires Shine to Accelerate the Path of Becoming Europe's Leading Financial Copilot for SMBs and Accountants26.11.2025 14:00:00 CET | Press release
Transformative combination creates a powerhouse for SMBs and accountants, empowering businesses across Europe by integrating leading suites of e-invoicing, digital accounting, business accounts and payments, and HR solutions into a unified platform. Cegid, a European leader in cloud software for finance, accounting, HR, and retail software, and Shine, a fast-growing European fintech unicorn providing digital business accounts and payments, e-invoicing, accounting, and payroll software to small businesses across Europe, announced today that the companies have entered a definitive agreement to join forces to form a European champion and become a leading provider of software for businesses and their accountants. This transformational combination will create the first fully integrated, cloud-native and AI-driven financial hub for SMBs and accounting professionals in Europe – bringing together market-leading capabilities in e-invoicing, accounting, digital business accounts and payments, ta
U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma26.11.2025 12:00:00 CET | Press release
If approved, sonrotoclax will become the first BCL2 inhibitor for R/R MCL in the U.S., addressing a high unmet need in an aggressive cancerSonrotoclax previously received Breakthrough Therapy Designation based on clinically meaningful, rapid responses in R/R MCLBeOne Medicines will present the data supporting the NDA and Priority Review for the first time at ASH 2025 BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to a New Drug Application (NDA) for sonrotoclax, a next-generation BCL2 inhibitor, for the treatment of adult patients with relapsed or refractory (R/R) mantle cell lymphoma (MCL), following treatment with a Bruton’s tyrosine kinase (BTK) inhibitor. “Sonrotoclax is advancing with remarkable speed, from Breakthrough Therapy Designation to Priority Review, all within a short window,” said Lai Wang, Ph.D., Global Head of R&D at BeOne.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom